I think she is doing some minor dilutions now, in hopes that upon anticipated approval, the coming forward moves won’t get bogged down by relatively inexpensive things that already show the next steps are happening — like the C lab, like further ramping, like the authorized share increase request, etc.
Market Data 
Markets 
AI
